DCR HBVS

· Dicerna Pharmaceuticals, Inc., a Novo Nordisk company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DCR HBVS, covering 2024-09-19 to 2024-09-19. Get the full timeline:

Most recent: Clinical Trial Update: Study of Safety and Tolerability of DCR HBVS [Phase 1]